Advertisements

Colecalciferolo Doc

Quick links to important sections

Colecalciferolo Doc

Advertisements

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Colecalciferolo Doc

Property Description
Active ingredient Colecalciferol (Vitamina D3)
Form Soluzione orale or Capsule molli
Pharmacological class Vitamina liposolubile (Fat-soluble vitamin)
Common use Profilassi e trattamento della carenza di Vitamina D
Origin Biosintetico (Biosynthetic)

Identity and Composition: What is Colecalciferolo Doc?

Colecalciferolo Doc is a medicinal product containing the active substance Colecalciferol, which is chemically identical to Vitamina D3 (Cholecalciferol). This product is defined as a farmaco a base di Colecalciferolo that functions as a prodotto monocomponente (single-component product). As a generic brand produced by Doc Generici, the preparation contains an active ingredient sourced as a biosintetico (biosynthetic) substance, structurally mirroring the Colecalciferol naturally synthesized by the body. This synthetic method is recognized for its purity and standardization in pharmaceutical manufacturing.

Type and Pharmaceutical Form: Is it a Vitamin or a Regulator?

Colecalciferol is classified pharmacologically as a vitamina liposolubile (fat-soluble vitamin). Furthermore, it is referred to functionally as a calcio-regolatore (calcium regulator) because of its systemic influence in regulating calcium homeostasis. Because it is fat-soluble, Colecalciferolo Doc is typically formulated as an oral solution (soluzione orale), often an oleosa (oily) soluzione galenica, or contained within soft capsules (capsule molli). The classification as a pro-ormone highlights its role as a precursor that the body converts into a metabolita attivo that governs mineral balance.

General Purpose: Why is Colecalciferol Essential?

The general purpose of Colecalciferolo Doc is the profilassi e trattamento della carenza di Vitamina D (prophylaxis and treatment of Vitamin D deficiency), which is necessary for maintaining systemic health. This medication facilitates the physiological action of enabling the small intestine to absorb calcio e fosfato (calcium and phosphate), supporting the process of omeostasi minerale (mineral homeostasis). By acting as a Mineral Absorption Facilitator, it is used to aid in regulating metabolismo osseo (bone metabolism) and ensuring the mantenimento della calcemia (maintenance of blood calcium levels), as Vitamin D is required for the body to absorb calcium and maintain bone health.

Advertisements

What side effects are possible with Colecalciferolo Doc?

Possible Side Effects and Safety Information

The official safety profile of Colecalciferol (Vitamin D3) is organized by regulatory authorities (such as the EMA and FDA) primarily around the management of mineral homeostasis and the potential for toxicity.


Adverse Reactions and Frequency Classification

Adverse reactions are primarily associated with elevated levels of calcium in the body, known as hypercalcaemia.

Classification System-Organ Class Specific Reactions
Uncommon (less than 1 in 100 people) Metabolism and Nutrition Disorders Hypercalcaemia, Hypercalciuria (excess calcium in urine)
Rare (less than 1 in 1,000 people) Skin and Subcutaneous Tissue Disorders Pruritus (itching), Rash, Urticaria (hives)

Serious Safety Considerations

The most significant safety concern documented is the risk of Hypervitaminosis D (toxicity), which is strictly linked to prolonged, high-dose exposure. This toxic state can lead to severe and potentially irreversible consequences due to excessive calcium deposition. Serious adverse reactions documented in regulatory sources include Irreversible renal insufficiency, Nephrocalcinosis (kidney calcification), widespread calcification of the soft tissues (e.g., blood vessels), and, in rare instances of severe toxicity, cardiac arrhythmias or coma.


Population-Specific Safety Constraints

The medicine is contraindicated in specific patient populations, including those with pre-existing Hypercalcaemia, Hypercalciuria, Nephrolithiasis (kidney stones), or Severe renal impairment. Regulatory documents also require caution in patients with sarcoidosis or those who are immobilized with osteoporosis, due to an increased risk of elevated calcium levels. Fetal harm is associated with prolonged maternal hypercalcaemia during pregnancy.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Colecalciferolo is officially documented as Hypervitaminosis D, a condition primarily resulting in severe Hypercalcemia (excessive calcium in the blood). The manifestations described in regulatory documentation include early systemic disturbances such as nausea, vomiting, constipation, generalized weakness, and persistent thirst.

The official overdose profile emphasizes the high risk of severe, potentially life-threatening systemic outcomes if this condition is left untreated. These consequences are documented to primarily affect the renal system, potentially causing irreversible renal failure, and the cardiovascular system, which can lead to arrhythmias and high blood pressure. Individuals with pre-existing conditions, such as chronic kidney or liver failure, are officially noted to have an increased risk for developing toxicity.

Regulatory authorities mandate clear emergency actions. Upon the suspicion or presence of any overdose symptoms, individuals must seek emergency medical attention immediately. If collapse, seizure, or difficulty breathing occurs, emergency services must be contacted without delay. Management focuses on the immediate discontinuation of Colecalciferol and providing symptomatic and supportive treatment (e.g., intravenous hydration) to correct the severe hypercalcemia. No specific antidote is known for Colecalciferol overdose; therefore, supportive care is required.

Advertisements

Therapeutic Uses of Colecalciferolo Doc

What Colecalciferolo Doc Treats: Main Uses and Benefits

Colecalciferolo Doc is relevant in situations involving symptoms related to systemic imbalance, specifically addressing deficient levels of Vitamin D (cholecalciferol). Its application is centered on helping to correct this imbalance and support various essential physiological functions.


Assisting with Functional Stability and Musculoskeletal Comfort

Colecalciferolo is generally used in areas where short-term symptom management is appropriate, particularly those involving the musculoskeletal system. The therapeutic domains often involve Vitamin D deficiency and providing support for conditions like osteoporosis. The medication is considered relevant for easing symptoms related to physical discomfort in the musculoskeletal system. This application is specifically relevant in contexts marked by increased discomfort or tension.

“This support helps improve day-to-day comfort during symptomatic periods.”

It provides support that helps ease the overall symptom burden associated with conditions where functional stability becomes affected.

Quick Fact: Relevant for Easing Musculoskeletal Discomfort


Management of Systemic and Episodic Manifestations

It is applied across domains where additional symptomatic support is needed, particularly in contexts involving heightened systemic burden. It is considered relevant for managing symptoms that may appear suddenly or intensify over time, including those that interfere with daily functioning and general well-being. This use assists with maintaining functional stability when symptoms are more noticeable, supporting the patient during difficult episodes by easing distress.

Regulatory References

  1. NIH MedlinePlus overview of Cholecalciferol
Advertisements

Eligibility and Restrictions for Use

Population Eligibility for Colecalciferolo Doc

The official regulatory profile strictly defines which patient groups are eligible for Colecalciferol (Vitamin D3) treatment and which must avoid it. Use is generally established for adults and adolescents from 12 years of age for deficiency or insufficiency, but is not recommended for children under 12 years.

Absolute Contraindications

Colecalciferolo Doc must not be used in patients with pre-existing conditions that reflect excess mineral levels or impaired metabolism. These absolute contraindications include:

  • Hypercalcaemia (high calcium levels in the blood)
  • Hypercalciuria (high calcium levels in the urine)
  • Hypervitaminosis D (Vitamin D toxicity)
  • Severe renal impairment
  • Calcium nephrolithiasis (kidney stones)

Restricted or Conditional Use

Use requires caution and close medical monitoring in patients with Sarcoidosis and those with Impairment of renal function (if not severe). During pregnancy, high-dose use is not recommended, but the medicine is permitted for breastfeeding women at recommended doses for documented deficiency.

Advertisements

What should I know about interactions with other medicines?

Official Regulatory Interaction Profile

The interactions documented for Colecalciferol are grouped based on the resulting change in exposure or toxicity risk, and the requirements for administration.

Interaction Type Interacting Substances/Classes Interaction-Related Constraint
Contraindicated Combination Other Vitamin D metabolites or analogues Co-administration is formally advised to be avoided (prohibited co-use).
Increased Toxicity Risk (Pharmacodynamic) Thiazide Diuretics (e.g., Hydrochlorothiazide) Increased risk of hypercalcaemia due to decreased renal calcium excretion.
Cardiac Glycosides (e.g., Digoxin) Potential potentiation of toxicity and risk of cardiac arrhythmias due to elevated calcium levels.
Reduced Effectiveness (Pharmacokinetic) Anticonvulsants (e.g., Phenytoin), Rifampicin Diminished pharmacological effect due to hepatic enzyme induction which accelerates Colecalciferol breakdown.
Impaired Absorption (Pharmacokinetic) Bile Acid Sequestrants (e.g., Cholestyramine), Orlistat, Mineral Oil Laxatives Requires mandatory timing separation from administration to mitigate reduced exposure.

Population and Timing Context

The regulatory profile includes timing-separation rules for absorption-impairing agents; for example, Colecalciferol must be taken at least four hours apart from bile acid sequestrants. Patients receiving Cardiac Glycosides or Thiazide Diuretics are noted to require close monitoring due to the pharmacodynamic risk. Sarcoidosis is an explicitly listed condition where interaction cautions apply due to the risk of increased conversion to the active metabolite. The use of aluminium-containing antacids for long periods is generally restricted due to potential interaction risks.

Advertisements

Mechanism of Action

How Colecalciferolo Doc works

This mechanism begins with Colecalciferol (Vitamin D3), a pro-hormone, undergoing enzymatic hydroxylation first in the liver and subsequently in the kidneys to form calcitriol (1,25-dihydroxyvitamin D). Calcitriol then acts as an agonist for the Vitamin D Receptor (VDR), a nuclear receptor found in target cells. The activated VDR-calcitriol complex dimerizes with the retinoid X receptor and binds to DNA sequences, altering the transcription rate of key genes. This intracellular process leads to the modulation of calcium and phosphate homeostasis by enhancing intestinal absorption and renal reabsorption of these minerals. Additionally, the mechanism involves direct action on the parathyroid gland, exerting a crucial negative feedback effect that suppresses the synthesis and secretion of Parathyroid Hormone (PTH). The resulting systemic mineral adjustments support the physicochemical process of bone matrix mineralization and contribute to the feedback regulation of systemic mineral levels.

Advertisements

Dosage and Administration Information

Administration and Official Dosing Guidelines

Colecalciferol is administered via the oral route, available in multiple dosage forms including capsules, tablets, and oil-based oral solutions. Due to its fat-soluble nature, the medicine is optimally absorbed when taken with a meal, preferably the main meal of the day.


Dosage Patterns and Schedule

Official regimens are typically divided into two procedural phases: an initial treatment phase, which uses a higher International Unit (IU) dose to correct deficiency, followed by a lower maintenance phase for sustained intake.

Administration Scope Official Guidelines
Dosing Schedule Daily doses commonly range from 800 IU to 4,000 IU for correction, or higher intermittent doses like 50,000 IU once weekly for several weeks. Maintenance is typically 800 IU to 2,000 IU daily.
Frequency Pattern Dosing can follow a daily schedule for lower strengths or an intermittent schedule (weekly or monthly) using higher-strength formulations to support patient adherence.
Preparation Capsules must be swallowed whole with water; liquid solutions require accurate measurement with a provided dispensing device.

Population Rules and Procedural Constraints

High-level rules for specific patient groups exist: standard Colecalciferol use is not recommended for individuals with severe renal impairment. Administration to adolescents and children over 12 years of age must occur under medical supervision. For all patients receiving long-term treatment, periodic monitoring of serum 25-hydroxyvitamin D levels is standard protocol, usually within three to four months of beginning the maintenance regimen.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Colecalciferolo Doc

Colecalciferolo Doc was studied for its association with Vitamin D status and systemic mineral levels. The evidence available comes primarily from formal clinical trials and systematic reviews of that research. Findings describe group patterns related to observations made under specific study conditions.


Evidence for Use in Correcting Vitamin D Deficiency

Research exploring deficiency correction primarily involves Randomized Controlled Trials (RCTs) that examine changes in serum 25-hydroxyvitamin D [25(OH)D] concentration, the primary biomarker for Vitamin D status. Findings describe patterns where Colecalciferol was observed alongside measurements of increased levels of this biomarker. Data show patterns related to shifts in parathyroid hormone (PTH) levels in some studies. Long-term effects are not fully established regarding sustained observation of biomarker levels over periods exceeding one year, and research lacks a universal consensus on an optimal target concentration for everyone.


Evidence for Use in Supporting Bone and Musculoskeletal Health

Research has explored this area, including large-scale, long-term RCTs that often investigated Colecalciferol in combination with calcium. Studies monitored structural outcomes, including changes to Bone Mineral Density (BMD) and the incidence of non-vertebral and hip fractures. Findings regarding the measured outcomes of Colecalciferol alone (without calcium co-intervention) on structural outcomes were reported as heterogeneous. The evidence quality varies because the independent contribution of the Vitamin D component is often not fully isolated.


Long-Term Research and Follow-up Duration

The research timeline for studies was studied for deficiency correction often runs for 3 to 12 months. For structural outcomes, the follow-up durations extended to intermediate to long-term periods (1 to 5 years). The primary goal of these extended observation periods was to observe data related to bone health and systemic mineral levels.


Key Limitations and Areas of Research Uncertainty

The overall evidence landscape has areas where certainty remains low. A significant limitation is that the results apply only to the populations studied, and the ability to generalize these findings to every individual is not fully established. For bone health outcomes, the comparative evidence is lacking for Colecalciferol used alone. Additionally, there is limited information for long-term outcomes that fully characterize observation over many years, and inconsistent findings were observed across some trials.

Key Studies & References

  1. Cholecalciferol (Vitamin D3) Overview: Drug Information
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Colecalciferolo Doc (FAQ)


Q: Is Colecalciferolo Doc the same as just taking a vitamin D supplement?

A: According to official regulatory documents, Colecalciferol is classified as a medicinal product or a prohormone. This establishes its regulatory role as a pharmaceutical agent specifically indicated for the prophylaxis and treatment of Vitamin D deficiency. This classification is used to distinguish it from general, non-pharmaceutical vitamin D products.


Q: How quickly should I expect to see any difference after starting Colecalciferolo Doc?

A: The effects of Colecalciferol are measured biochemically rather than by immediate physical feeling. Official guidelines indicate that healthcare professionals typically recommend follow-up blood measurements of Vitamin D levels (specifically, serum 25-hydroxyvitamin D) approximately three to four months after starting maintenance therapy. This timeframe is typically used to assess changes in the body's status toward a target level.


Q: Is it normal to not feel any different when taking Colecalciferolo Doc?

A: The primary function of Colecalciferol is to regulate internal biochemical processes, specifically the homeostasis of calcium and phosphate. Because this action occurs at a cellular and systemic level, patients generally do not feel a direct physical sensation or immediate change when taking the medication as prescribed.


Q: Can Colecalciferolo Doc affect my mood or energy levels?

A: Official safety warnings describe symptoms such as weakness, fatigue, headache, and drowsiness as potential signs. However, these effects are typically associated with excessive intake and are mentioned in the context of Vitamin D toxicity (overdose). They are not listed among the commonly reported side effects when the product is used as directed.


Q: Can I take Colecalciferolo Doc if I have kidney stones?

A: According to official regulatory documents, this medicine is contraindicated in patients with specific pre-existing conditions. These conditions include Nephrolithiasis (kidney stones) and Hypercalciuria (excess calcium in the urine). Use of the product is generally avoided in these circumstances due to the potential for it to increase calcium levels.


Q: Can people with certain gut issues, like Crohn's disease, use Colecalciferolo Doc?

A: Official guidelines specifically note that individuals with conditions that cause malabsorption, such as inflammatory bowel disease or coeliac disease, are at higher risk of deficiency. For these populations, regulatory guidance suggests that higher doses and specialized monitoring of Vitamin D levels may be considered.


Q: Can Colecalciferolo Doc be used during the winter months when there is less sun?

A: Official sources identify a lack of sun exposure as a primary risk factor for Vitamin D deficiency. Because the body's natural synthesis of Vitamin D is limited during periods of low sunlight, such as in winter months, the use of Colecalciferol is supported by regulatory indication to address this common cause of deficiency.


Q: Is Colecalciferolo Doc effective for people with darker skin tones?

A: Regulatory guidelines identify dark skinned individuals as a population at high risk of developing Vitamin D deficiency. Due to differences in natural Vitamin D synthesis, these individuals may require higher doses and closer, specialized monitoring of their serum Vitamin D levels to address the risk of deficiency in this population.


Q: Does the time of day matter when taking Colecalciferolo Doc?

A: Official administration instructions emphasize that the medicine is optimally absorbed when taken with a meal, particularly the main meal of the day, due to its fat-soluble nature. However, regulatory documents do not specify a required time of day (such as morning versus evening) for administration.


Q: How does obesity affect the use of Colecalciferolo Doc?

A: Official guidelines cite obese individuals as a population at high risk for Vitamin D deficiency. Because Colecalciferol is fat-soluble and can be stored differently in adipose (fat) tissue, regulatory documents suggest that individuals in this population may require higher doses and specialized monitoring to address the risk of deficiency in this population.


Q: What should I know about taking Colecalciferolo Doc if I am lactose intolerant?

A: Official product information indicates that the excipient list for certain Colecalciferol formulations may include ingredients like lactose or sucrose. Regulatory warnings advise that patients with these specific intolerances (such as Lapp lactase deficiency) are generally advised to avoid that specific medicinal product.


Q: Is Colecalciferolo Doc used to treat osteoporosis?

A: Official indications state the medicine is for use as an adjunct (in addition) to specific therapy for osteoporosis in adults who also have a documented Vitamin D deficiency or are at risk of developing one.


Q: Can Colecalciferolo Doc affect my sleep?

A: The official safety profile lists drowsiness as a potential symptom. However, this symptom is specifically mentioned as a possible early sign of Vitamin D toxicity resulting from excessive intake or overdose, not as a typical side effect when the product is used at recommended levels.


Q: Are there known interactions between Colecalciferolo Doc and certain herbal supplements?

A: The official regulatory interaction profile primarily focuses on established interactions with other prescription medicines and widely used over-the-counter drugs. Regulatory documents state that this list is not necessarily all-inclusive and may not contain specific information regarding every individual herbal supplement.


Q: What should I do if I think I am experiencing a side effect from Colecalciferolo Doc?

A: Regulatory guidance indicates that patients experiencing symptoms suggestive of overdose or serious adverse reactions should seek medical attention. Furthermore, official safety constraints mandate that patients receiving long-term treatment require periodic monitoring of mineral levels by a healthcare professional.


Q: Does Colecalciferolo Doc need to be taken with food, or can I take it on an empty stomach?

A: Due to the drug's fat-soluble nature, regulatory documents state that the medicine is optimally absorbed when taken with a meal, preferably the main meal of the day. This recommendation is made to maximize the absorption of Colecalciferol in the body.


Q: Can I crush or open the capsule/tablet of Colecalciferolo Doc?

A: The official method of administration instructions specify that capsules must be swallowed whole with water. In contrast, liquid solutions are designed for administration and require the use of a provided dispensing device for accurate measurement.


Q: Is Colecalciferolo Doc a prescription-only medicine?

A: While some lower-strength Vitamin D products are available over-the-counter, high-strength formulations of Colecalciferol used for the treatment of severe deficiency are typically classified as prescription-only medicinal products. This is due to the potential risks associated with higher doses, necessitating frequent medical monitoring to confirm patient safety.


Q: Why is a prescription needed for Colecalciferolo Doc when Vitamin D is available over the counter?

A: A prescription is typically required for the high-strength formulations of Colecalciferol that are used to treat severe deficiencies. These higher doses carry an increased risk of elevated calcium levels (hypercalcaemia) and therefore necessitate periodic medical monitoring to ensure safe and appropriate use.


Q: Does Colecalciferolo Doc interact with caffeine?

A: Official regulatory documents outlining known drug interactions, as well as general drug interaction resources, do not list caffeine. This means that caffeine is not a substance that has a documented or significant pharmacokinetic interaction with Colecalciferol.


Q: Does Colecalciferolo Doc interact with any common pain relievers like ibuprofen or aspirin?

A: Official regulatory documents and drug interaction resources detailing known interactions do not list common pain relievers such as Ibuprofen or Aspirin. These substances are therefore not cited as having a known or significant pharmacokinetic interaction with Colecalciferol.


Q: What is the shelf life of Colecalciferolo Doc?

A: The shelf life for Colecalciferol formulations is typically defined in official documents as being 18 to 36 months from the date of manufacture, provided the product is stored according to instruction. Regulatory rules mandate that the medicine must not be used after the expiry date printed on the packaging.


Q: Are there different forms of Colecalciferolo Doc available (e.g., tablet, liquid, chewable)?

A: Colecalciferol is manufactured in several dosage forms. The official product information covers capsules, tablets, and various oral solutions (often oily solutions or drops). In certain regions, the product is also available as chewable tablets or wafers.


Q: What if I forget to take Colecalciferolo Doc for a few days?

A: The procedure for a missed dose is detailed in official patient instructions. Instructions generally state that if a dose is forgotten, it may be taken as soon as it is remembered, unless it is almost time for the next scheduled dose. Importantly, instructions strictly advise patients not to take two doses at one time to compensate for the forgotten dose.

Advertisements

How should Colecalciferolo Doc be stored and disposed of?

How to Store and Dispose of Colecalciferolo Doc

The storage and disposal requirements for Colecalciferolo (Vitamin D3) are strictly defined by regulatory documents to maintain product quality and safety.

Storage Conditions

Requirement Official Instruction
Temperature Store below 25 C
Protection Keep in the original package to ensure protection from light and moisture
Children Keep out of the sight and reach of children

Certain liquid formulations are also specified to be kept from freezing. The medicine's shelf life is typically 36 months when stored according to these conditions.

Disposal

There are no special requirements for disposal of the capsules. Any unused or expired product must be disposed of in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Colecalciferolo Doc found in:

A-Z Index: